{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:46:32Z","timestamp":1791009992526,"version":"4.1.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Phage display technology has emerged as a versatile platform for vaccine development by integrating antigen presentation with intrinsic immunostimulatory properties. Among the available phage systems, the filamentous bacteriophage M13 has attracted considerable attention because of its structural versatility, genetic programmability, and capacity for diverse antigen display strategies. Recent studies have demonstrated the potential of M13-based vaccines to induce robust humoral and cellular immune responses against a broad spectrum of animal viral, bacterial, and parasitic pathogens. This review critically summarizes current advances in M13 phage-based vaccine development, with particular emphasis on structural characteristics, antigen display strategies, immune mechanisms, and representative veterinary applications. In addition, we discuss key challenges associated with commercial translation, including scalable manufacturing, quality control, formulation stability, and future development. By integrating recent progress with remaining challenges, this review provides an updated perspective on the rational design and translational development of next-generation M13 phage-based veterinary vaccines.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1882961","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:26Z","timestamp":1784095886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["M13 phage-based antigen presentation and immune response activation in vaccine development for animal infectious diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Guodong","family":"Zhou","sequence":"first","affiliation":[{"name":"College of Agriculture and Biology, Liaocheng University","place":["Liaocheng, Shandong, China"]},{"name":"Shandong Key Laboratory of Applied Technology for Protein and Peptide Drugs, Liaocheng University","place":["Liaocheng, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Agriculture and Biology, Liaocheng University","place":["Liaocheng, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Key Laboratory of Applied Technology for Protein and Peptide Drugs, Liaocheng University","place":["Liaocheng, Shandong, China"]},{"name":"College of Pharmaceutical Sciences and Food Engineering, Liaocheng University","place":["Liaocheng, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Agriculture and Biology, Liaocheng University","place":["Liaocheng, Shandong, China"]},{"name":"Shandong Key Laboratory of Applied Technology for Protein and Peptide Drugs, Liaocheng University","place":["Liaocheng, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Li","sequence":"additional","affiliation":[{"name":"College of Agriculture and Biology, Liaocheng University","place":["Liaocheng, Shandong, China"]},{"name":"Shandong Key Laboratory of Applied Technology for Protein and Peptide Drugs, Liaocheng University","place":["Liaocheng, Shandong, China"]},{"name":"College of Pharmaceutical Sciences and Food Engineering, Liaocheng University","place":["Liaocheng, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2009.0133","article-title":"Livestock infectious diseases and zoonoses","volume":"364","author":"Tomley","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvfa.2024.01.001","article-title":"Foot-and-mouth disease","author":"Arzt","year":"2024","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00234-2","article-title":"Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control","volume":"24","author":"Kang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2155072","article-title":"Alarming situation of emerging H5 and H7 avian influenza and effective control strategies","volume":"12","author":"Shi","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12112191","article-title":"Spillover: mechanisms, genetic barriers, and the role of reservoirs in emerging pathogens","volume":"12","author":"Pauciullo","year":"2024","journal-title":"Microorganisms"},{"key":"B7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.15212\/ZOONOSES-2021-0028","article-title":"The animal origin of major human infectious diseases: what can past epidemics teach us about preventing the next pandemic","volume":"2","author":"Dharmarajan","year":"2022","journal-title":"Zoonoses"},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-4419-1278-7_15","article-title":"Pathogen virulence genes: Advances, challenges and future directions in infectious disease research","volume":"56","author":"Chen","year":"2025","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.23055\/ijietap.2026.33.1.11445","article-title":"Decarbonization through digital twins: Integrating management competencies and industrial energy efficiency","volume":"33","author":"Zhou","year":"2026","journal-title":"Int J Ind Eng"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5713\/ajas.20.0156","article-title":"Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - a review","volume":"33","author":"Cheng","year":"2020","journal-title":"Asian-Australas J Anim Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1507469","article-title":"Non-vaccinal prophylaxis of tularemia","volume":"15","author":"Maurin","year":"2024","journal-title":"Front Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/00084433.2025.2487727","article-title":"Ultrasonic electrolysis enhanced coal flotation quality effect and economic research","volume":"65","author":"Zhou","year":"2026","journal-title":"Can Metall Q"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2347019","article-title":"Pandemic preparedness through vaccine development for avian influenza viruses","volume":"20","author":"Cargnin Faccin","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13028-020-00519-1","article-title":"Towards improvements in foot-and-mouth disease vaccine performance","volume":"62","author":"Belsham","year":"2020","journal-title":"Acta Vet Scand"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/vim.2017.0049","article-title":"Adjuvants for animal vaccines","volume":"31","author":"Burakova","year":"2018","journal-title":"Viral Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2385500","article-title":"Features of the SARS-CoV-2 KP. 3 variant mutations","volume":"56","author":"Branda","year":"2024","journal-title":"Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2232760","DOI":"10.1001\/jamanetworkopen.2022.32760","article-title":"Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1326154","article-title":"Two centuries of vaccination: historical and conceptual approach and future perspectives","volume":"11","author":"Montero","year":"2023","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/ba20000034","article-title":"Design and production of recombinant subunit vaccines","volume":"32","author":"Hansson","year":"2000","journal-title":"Biotechnol Appl Biochem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.24875\/aidsrev.25000009","article-title":"Integrating business management strategies to address HIV stigma and support employees in diverse workplaces","volume":"27","author":"Zhou","year":"2025","journal-title":"AIDS Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s43556-024-00222-x","article-title":"Prophylactic and therapeutic vaccine development: advancements and challenges","volume":"5","author":"Weerarathna","year":"2024","journal-title":"Mol BioMed"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030689","article-title":"Uncovering the drivers of childhood immunization inequality with caregivers, community members and health system stakeholders: Results from a human-centered design study in DRC, Mozambique and Nigeria","volume":"11","author":"Shearer","year":"2023","journal-title":"Vaccines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.2019.1667042","article-title":"Vaccine approaches for the 'therapeutic management' of Mycobacterium avium subspecies paratuberculosis infection in domestic livestock","volume":"39","author":"Gupta","year":"2019","journal-title":"Vet Q"},{"key":"B25","doi-asserted-by":"publisher","first-page":"123925","DOI":"10.1016\/j.envres.2026.123925","article-title":"Commercialization path of data-driven green catalytic technology: the application of machine learning in technology lifecycle management","volume":"296","author":"Zhou","year":"2026","journal-title":"Environ Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030037","article-title":"Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system","volume":"6","author":"Mohsen","year":"2018","journal-title":"Vaccines"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2017.09.003","article-title":"Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation","volume":"34","author":"Silva","year":"2017","journal-title":"Semin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.addr.2018.06.025","article-title":"Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases","volume":"145","author":"Tao","year":"2019","journal-title":"Adv Drug Delivery Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/1040841x.2023.2219741","article-title":"Applications of the phage display technology in molecular biology, biotechnology and medicine","volume":"50","author":"Pierzynowska","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12929-016-0285-9","article-title":"Phage display as a promising approach for vaccine development","volume":"23","author":"Aghebati-Maleki","year":"2016","journal-title":"J BioMed Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117132","article-title":"Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy","volume":"238","author":"Fadaie","year":"2023","journal-title":"Environ Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-023-04606-w","article-title":"M13 phage: a versatile building block for a highly specific analysis platform","volume":"415","author":"Wang","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.6.3.333-339.1970","article-title":"Increased fragility of Escherichia coli after infection with bacteriophage M13","volume":"6","author":"Roy","year":"1970","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-2508(03)00067-6","article-title":"Bacteriophage observations and evolution","volume":"154","author":"Ackermann","year":"2003"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-006-0849-1","article-title":"5500 phages examined in the electron microscope","volume":"152","author":"Ackermann","year":"2007"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-72077-7_1","article-title":"Filamentous phage: structure and biology","volume":"1053","author":"Rakonjac","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab052","article-title":"Phage display and other peptide display technologies","volume":"46","author":"Jaroszewicz","year":"2022","journal-title":"FEMS Microbiol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(80)90093-1","article-title":"Nucleotide sequence of the filamentous bacteriophage M13 DNA genome: comparison with phage fd","volume":"11","author":"van Wezenbeek","year":"1980","journal-title":"Gene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100612","article-title":"Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy","volume":"20","author":"Chang","year":"2023","journal-title":"Mater Today Bio"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/cr000261r","article-title":"Filamentous phage display in the new millennium","volume":"105","author":"Kehoe","year":"2005","journal-title":"Chem Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/BF00990543","article-title":"Single-stranded DNA binding protein encoded by the filamentous bacteriophage M13: structural and functional characteristics","volume":"20","author":"Stassen","year":"1994","journal-title":"Mol Biol Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117880","article-title":"Recent advances in M13 phage display: Novel strategies of construction and biopanning recognition elements for food safety detection","volume":"289","author":"Liu","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"B43","first-page":"51","article-title":"Filamentous bacteriophage: biology, phage display and nanotechnology applications","volume":"13","author":"Rakonjac","year":"2011","journal-title":"Curr Issues Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00567-12","article-title":"Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites","volume":"56","author":"Huang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(84)90049-7","article-title":"Gene-III protein of filamentous phages: evidence for a carboxyl-terminal domain with a role in morphogenesis","volume":"132","author":"Crissman","year":"1984"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0298-140","article-title":"The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p","volume":"5","author":"Lubkowski","year":"1998"},{"key":"B47","doi-asserted-by":"publisher","first-page":"pdb.over107754","DOI":"10.1101\/pdb.over107754","article-title":"Structure, biology, and applications of filamentous bacteriophages","volume":"2024","author":"Rakonjac","year":"2023","journal-title":"Cold Spring Harbor Protoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4684-2712-7_1","article-title":"The single-stranded DNA phages","volume":"4","author":"Denhardt","year":"1975"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/5.12.4495","article-title":"Nucleotide sequence of an RNA polymerase binding site from the DNA of bacteriophage fd","volume":"72","author":"Schaller","year":"1975"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.11.4002","article-title":"Translational repression in bacteriophage f1: characterization of the gene V protein target on the gene II mRNA","volume":"86","author":"Michel","year":"1989"},{"key":"B51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-2836(88)90090-3","article-title":"Regulation of bacteriophage f1 DNA replication: I. New functions for genes II and X","volume":"203","author":"Fulford","year":"1988","journal-title":"J Mol Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3227","article-title":"The pI and pXI assembly proteins serve separate and essential roles in filamentous phage assembly","volume":"293","author":"Haigh","year":"1999","journal-title":"J Mol Biol"},{"key":"B53","article-title":"Next generation phage display by use of pVII and pIX as display scaffolds","volume":"58","author":"L\u00f8set","year":"2012"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1038\/s41467-023-37915-w","article-title":"Cryo-electron microscopy of the f1 filamentous phage reveals insights into viral infection and assembly","volume":"14","author":"Conners","year":"2023"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-2836(02)00260-7","article-title":"Delineating the site of interaction on the pIII protein of filamentous bacteriophage fd with the F-pilus of Escherichia coli","volume":"319","author":"Deng","year":"2002","journal-title":"J Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2177978","article-title":"SpyDisplay: A versatile phage display selection system using SpyTag\/SpyCatcher technology","volume":"15","author":"Kellmann","year":"2023","journal-title":"mAbs"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2012.01.038","article-title":"Phagemid vectors for phage display: properties, characteristics and construction","volume":"417","author":"Qi","year":"2012","journal-title":"J Mol Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature24650","article-title":"Biotechnological mass production of DNA origami","volume":"552","author":"Praetorius","year":"2017","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202212011","article-title":"Catalytic DNA-assisted mass production of arbitrary single-stranded DNA","volume":"62","author":"Zhang","year":"2023","journal-title":"Angewandte Chemie (International Ed English)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01065-5","article-title":"Single-cell profiling of proteins and chromatin accessibility using PHAGE-ATAC","volume":"40","author":"Fiskin","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"PNAS"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202510229","article-title":"A programmable nanovaccine platform based on M13 bacteriophage for personalized cancer vaccine and therapy","volume":"37","author":"Huang","year":"2025","journal-title":"Advanced Materials (Deerfield Beach Fla)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202505791","article-title":"Engineering M13 filamentous phages to target dendritic cells and elicit anti-tumour immunity","author":"AuYeung","year":"2025","journal-title":"Small (Weinheim der Bergstrasse Germany)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/viro.2000.0185","article-title":"Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2","volume":"269","author":"Grabowska","year":"2000","journal-title":"Virology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","article-title":"Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling","volume":"402","author":"Hashiguchi","year":"2010"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00755","article-title":"Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold","volume":"6","author":"Henry","year":"2015","journal-title":"Front Microbiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.21.11455","article-title":"Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration","volume":"97","author":"Frenkel","year":"2000","journal-title":"PNAS"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00377-6","article-title":"Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages","volume":"17","author":"De Berardinis","year":"1999","journal-title":"Vaccine"},{"key":"B69","article-title":"Rational design of an HIV-1 vaccine using a filamentous phage carrier","author":"Bailey","year":"2013"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/894971","article-title":"Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses","volume":"2010","author":"Del Pozzo","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425322","article-title":"Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments","volume":"35","author":"Wan","year":"2005"},{"key":"B72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0378-1119(93)90156-w","article-title":"Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage","volume":"128","author":"Willis","year":"1993","journal-title":"Gene"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27714","article-title":"Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB\/c mice","volume":"10","author":"Wang","year":"2014","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.07.005","article-title":"Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL\/6 mice","volume":"23","author":"Yang","year":"2005","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.05.024","article-title":"The potential of phage display virions expressing Malignant tumor specific antigen MAGE-A1 epitope in murine model","volume":"23","author":"Fang","year":"2005"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"van Houten","year":"2010","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c16246","article-title":"Dual-engineered phage vaccine platform facilitates STING activation for influenza protection","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl Materials Interfaces"},{"key":"B78","doi-asserted-by":"publisher","first-page":"25382","DOI":"10.1038\/s41598-024-74438-w","article-title":"Designing a multi-epitope influenza vaccine: an immunoinformatics approach","volume":"14","author":"Momajadi","year":"2024","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cimid.2019.05.004","article-title":"Immunological properties of the SLLTEVET epitope of Influenza A virus in multiple display on filamentous M13 phage","volume":"65","author":"Lotfi","year":"2019","journal-title":"Comp Immunology Microbiol Infect Dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107325","article-title":"Bacteriophage M13KE as a nanoparticle platform to display and deliver a pathogenic epitope: Development of an effective porcine epidemic diarrhoea virus vaccine","volume":"200","author":"Li","year":"2025","journal-title":"Microb Pathogen"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2016.05.027","article-title":"Injected phage-displayed-VP28 vaccine reduces shrimp Litopenaeus vannamei mortality by white spot syndrome virus infection","volume":"55","author":"Sol\u00eds-Lucero","year":"2016","journal-title":"Fish Shellfish Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s10482-007-9195-x","article-title":"Presentation of the functional receptor-binding domain of the bacterial adhesin F17a-G on bacteriophage M13","volume":"93","author":"Van Gerven","year":"2008","journal-title":"Antonie van Leeuwenhoek"},{"key":"B83","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1128\/cmr.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/ani12030264","article-title":"Antimicrobial susceptibility of enterotoxigenic Escherichia coli from diarrhoeic neonatal calves in Spain","volume":"12","author":"Prieto","year":"2022","journal-title":"Animals"},{"key":"B86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/mrm.0000000000000438","article-title":"The important F17 fimbriae contribution in pathogenic Escherichia coli infection","author":"Dhehibi","year":"2025","journal-title":"Rev Res Med Microbiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2015.590-598","article-title":"Role of parasitic vaccines in integrated control of parasitic diseases in livestock","volume":"8","author":"Sharma","year":"2015","journal-title":"Veterinary World"},{"key":"B88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vetimm.2003.12.009","article-title":"Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis","volume":"99","author":"Manoutcharian","year":"2004","journal-title":"Veterinary Immunol Immunopathology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m110275200","article-title":"Selection and identification of dense granule antigen GRA3 by Toxoplasma gondii whole genome phage display","volume":"277","author":"Robben","year":"2002","journal-title":"J Biol Chem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-010720-052252","article-title":"Plant viruses and bacteriophage-based reagents for diagnosis and therapy","volume":"7","author":"Shukla","year":"2020","journal-title":"Annu Rev Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1882961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:28Z","timestamp":1784095888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1882961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2026.1882961"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1882961","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1882961"}}